Streetbeat News

Analyst Ratings

BLUE

KE

PPC

SCSC

SNOW

Top Wall Street analysts have downgraded several notable stocks, including Snowflake Inc. (SNOW), bluebird bio, Inc. (BLUE), Pilgrim’s Pride Corporation (PPC), ScanSource, Inc. (SCSC), and Kimball Electronics, Inc. (KE). These downgrades reflect changes in analyst sentiment and price targets, impacting the short-term outlook for these companies.

Portfolio Pulse from Avi Kapoor

August 15, 2024 | 12:29 pm

NJR

JP Morgan analyst Richard Sunderland maintains a Neutral rating on New Jersey Resources (NYSE:NJR) and raises the price target from $48 to $49.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:28 pm

SNOW

Snowflake shares are trading lower after Wells Fargo downgraded the stock from Overweight to Equal-Weight and lowered its price target from $200 to $130.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:28 pm

SPIR

Craig-Hallum analyst Jeff Van Rhee has downgraded Spire Global (NYSE:SPIR) from Buy to Hold and lowered the price target from $13 to $8.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:27 pm

ATO

JP Morgan analyst Richard Sunderland maintains an Overweight rating on Atmos Energy (NYSE:ATO) and raises the price target from $134 to $144.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:26 pm

GPCR

Cantor Fitzgerald analyst Prakhar Agrawal has reiterated an Overweight rating on Structure Therapeutics (NASDAQ:GPCR) and maintained a $65 price target.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:22 pm

ZURA

Cantor Fitzgerald analyst Josh Schimmer has reiterated an Overweight rating on Zura Bio (NASDAQ:ZURA).

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:20 pm

LYRA

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Lyra Therapeutics (NASDAQ:LYRA).

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:19 pm

CELC

Stifel analyst Bradley Canino maintains a Buy rating on Celcuity (NASDAQ:CELC) but lowers the price target from $40 to $39.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:16 pm

PYCR

Stifel analyst Brad Reback maintains a Buy rating on Paycor HCM (NASDAQ:PYCR) but lowers the price target from $22 to $19.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 12:15 pm